NCT06863259 2026-02-18Study of Inotuzumab Ozogamicin, Venetoclax, and Dexamethasone for Relapsed B-cell ALLChildren's Hospital Medical Center, CincinnatiPhase 1 Recruiting28 enrolled
NCT06287229 2026-02-17Phase Ib/II Study Assessing the Clinical Activity and Safety of Brexucabtagene Autoleucel as a Consolidation in Patients With Relapsed/Refractory (R/R) and Newly Diagnosed B-cell Acute Lymphocytic Leukemia (ALL) Post Cytoreduction With Mini-HCVD-inotuzumab-blinatumomab/HCVAD-inotuzumab-blinatumomabM.D. Anderson Cancer CenterPhase 1/2 Recruiting40 enrolled